Prothrombin Complex Concentrate Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (3 Factor PCC, 4 Factor PCC); Application (Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency); End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others)

Report Code: TIPRE00018528 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Therapy consists of blood clotting factors II, IX and X Prothrombin complex concentrates. Described as factor IX complex, it is commonly used during heavy bleeding and includes reverse anticoagulation in emergency situations.

MARKET DYNAMICS

Increasing prescribing anticoagulants, in particular warfarin, and an increased incidence of bleeding disorders are projected to expand the marketplace. Compared to fresh-frozen plasma and others, PCC provides a variety of benefits that make it ideally suited to life-threatening situations. A total of 68,703,141 I.U. According to the Federation of World Hemophilia. Plasma-derived factor IX was used in Europe in 2018. Increased use of the factor IX complex would therefore likely lead to the growth of this market during the forecast era.

MARKET SCOPE

The "Prothrombin Complex Concentrate Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Prothrombin Complex Concentrate Market with detailed market segmentation by type, application, and end use. The Prothrombin Complex Concentrate Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Prothrombin Complex Concentrate Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Prothrombin Complex Concentrate Market is segmented on the basis of type, application, and end use. Based on product type, the market is segmented as 3 Factor PCC, 4 Factor PCC. Based on application, the market is segmented as Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency. Based on end use, the market is segmented as Hospitals and Clinics, Ambulatory Surgical Centers, and Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Prothrombin Complex Concentrate Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prothrombin Complex Concentrate Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Prothrombin Complex Concentrate Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prothrombin Complex Concentrate Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Prothrombin Complex Concentrate Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Prothrombin Complex Concentrate Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Prothrombin Complex Concentrate Market in the global market. Below mentioned is the list of few companies engaged in the Prothrombin Complex Concentrate Market.

The report also includes the profiles of key players in Prothrombin Complex Concentrate Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Takeda Pharmaceutical Company Limited
  •   China Biologic Products Holdings, Inc.
  •   Sanquin
  •   CSL Behring
  •   Kedrion S.p.A
  •   Octopharma AG
  •   Grifols, S.A.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prothrombin Complex Concentrate Market - By Type
1.3.2 Prothrombin Complex Concentrate Market - By Application
1.3.3 Prothrombin Complex Concentrate Market - By End Use
1.3.4 Prothrombin Complex Concentrate Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROTHROMBIN COMPLEX CONCENTRATE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROTHROMBIN COMPLEX CONCENTRATE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROTHROMBIN COMPLEX CONCENTRATE MARKET - GLOBAL MARKET ANALYSIS
6.1. PROTHROMBIN COMPLEX CONCENTRATE - GLOBAL MARKET OVERVIEW
6.2. PROTHROMBIN COMPLEX CONCENTRATE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PROTHROMBIN COMPLEX CONCENTRATE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 3 FACTOR PCC
7.3.1. Overview
7.3.2. 3 Factor PCC Market Forecast and Analysis
7.4. 4 FACTOR PCC
7.4.1. Overview
7.4.2. 4 Factor PCC Market Forecast and Analysis
8. PROTHROMBIN COMPLEX CONCENTRATE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ACQUIRED COAGULATION FACTOR DEFICIENCY AND CONGENITAL COAGULATION FACTOR DEFICIENCY
8.3.1. Overview
8.3.2. Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency Market Forecast and Analysis
9. PROTHROMBIN COMPLEX CONCENTRATE MARKET - REVENUE AND FORECASTS TO 2027 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. AND OTHERS
9.5.1. Overview
9.5.2. and Others Market Forecast and Analysis
10. PROTHROMBIN COMPLEX CONCENTRATE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Prothrombin Complex Concentrate Market Overview
10.1.2 North America Prothrombin Complex Concentrate Market Forecasts and Analysis
10.1.3 North America Prothrombin Complex Concentrate Market Forecasts and Analysis - By Type
10.1.4 North America Prothrombin Complex Concentrate Market Forecasts and Analysis - By Application
10.1.5 North America Prothrombin Complex Concentrate Market Forecasts and Analysis - By End Use
10.1.6 North America Prothrombin Complex Concentrate Market Forecasts and Analysis - By Countries
10.1.6.1 United States Prothrombin Complex Concentrate Market
10.1.6.1.1 United States Prothrombin Complex Concentrate Market by Type
10.1.6.1.2 United States Prothrombin Complex Concentrate Market by Application
10.1.6.1.3 United States Prothrombin Complex Concentrate Market by End Use
10.1.6.2 Canada Prothrombin Complex Concentrate Market
10.1.6.2.1 Canada Prothrombin Complex Concentrate Market by Type
10.1.6.2.2 Canada Prothrombin Complex Concentrate Market by Application
10.1.6.2.3 Canada Prothrombin Complex Concentrate Market by End Use
10.1.6.3 Mexico Prothrombin Complex Concentrate Market
10.1.6.3.1 Mexico Prothrombin Complex Concentrate Market by Type
10.1.6.3.2 Mexico Prothrombin Complex Concentrate Market by Application
10.1.6.3.3 Mexico Prothrombin Complex Concentrate Market by End Use
10.2. EUROPE
10.2.1 Europe Prothrombin Complex Concentrate Market Overview
10.2.2 Europe Prothrombin Complex Concentrate Market Forecasts and Analysis
10.2.3 Europe Prothrombin Complex Concentrate Market Forecasts and Analysis - By Type
10.2.4 Europe Prothrombin Complex Concentrate Market Forecasts and Analysis - By Application
10.2.5 Europe Prothrombin Complex Concentrate Market Forecasts and Analysis - By End Use
10.2.6 Europe Prothrombin Complex Concentrate Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Prothrombin Complex Concentrate Market
10.2.6.1.1 Germany Prothrombin Complex Concentrate Market by Type
10.2.6.1.2 Germany Prothrombin Complex Concentrate Market by Application
10.2.6.1.3 Germany Prothrombin Complex Concentrate Market by End Use
10.2.6.2 France Prothrombin Complex Concentrate Market
10.2.6.2.1 France Prothrombin Complex Concentrate Market by Type
10.2.6.2.2 France Prothrombin Complex Concentrate Market by Application
10.2.6.2.3 France Prothrombin Complex Concentrate Market by End Use
10.2.6.3 Italy Prothrombin Complex Concentrate Market
10.2.6.3.1 Italy Prothrombin Complex Concentrate Market by Type
10.2.6.3.2 Italy Prothrombin Complex Concentrate Market by Application
10.2.6.3.3 Italy Prothrombin Complex Concentrate Market by End Use
10.2.6.4 Spain Prothrombin Complex Concentrate Market
10.2.6.4.1 Spain Prothrombin Complex Concentrate Market by Type
10.2.6.4.2 Spain Prothrombin Complex Concentrate Market by Application
10.2.6.4.3 Spain Prothrombin Complex Concentrate Market by End Use
10.2.6.5 United Kingdom Prothrombin Complex Concentrate Market
10.2.6.5.1 United Kingdom Prothrombin Complex Concentrate Market by Type
10.2.6.5.2 United Kingdom Prothrombin Complex Concentrate Market by Application
10.2.6.5.3 United Kingdom Prothrombin Complex Concentrate Market by End Use
10.2.6.6 Rest of Europe Prothrombin Complex Concentrate Market
10.2.6.6.1 Rest of Europe Prothrombin Complex Concentrate Market by Type
10.2.6.6.2 Rest of Europe Prothrombin Complex Concentrate Market by Application
10.2.6.6.3 Rest of Europe Prothrombin Complex Concentrate Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Prothrombin Complex Concentrate Market Overview
10.3.2 Asia-Pacific Prothrombin Complex Concentrate Market Forecasts and Analysis
10.3.3 Asia-Pacific Prothrombin Complex Concentrate Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Prothrombin Complex Concentrate Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Prothrombin Complex Concentrate Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Prothrombin Complex Concentrate Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Prothrombin Complex Concentrate Market
10.3.6.1.1 Australia Prothrombin Complex Concentrate Market by Type
10.3.6.1.2 Australia Prothrombin Complex Concentrate Market by Application
10.3.6.1.3 Australia Prothrombin Complex Concentrate Market by End Use
10.3.6.2 China Prothrombin Complex Concentrate Market
10.3.6.2.1 China Prothrombin Complex Concentrate Market by Type
10.3.6.2.2 China Prothrombin Complex Concentrate Market by Application
10.3.6.2.3 China Prothrombin Complex Concentrate Market by End Use
10.3.6.3 India Prothrombin Complex Concentrate Market
10.3.6.3.1 India Prothrombin Complex Concentrate Market by Type
10.3.6.3.2 India Prothrombin Complex Concentrate Market by Application
10.3.6.3.3 India Prothrombin Complex Concentrate Market by End Use
10.3.6.4 Japan Prothrombin Complex Concentrate Market
10.3.6.4.1 Japan Prothrombin Complex Concentrate Market by Type
10.3.6.4.2 Japan Prothrombin Complex Concentrate Market by Application
10.3.6.4.3 Japan Prothrombin Complex Concentrate Market by End Use
10.3.6.5 South Korea Prothrombin Complex Concentrate Market
10.3.6.5.1 South Korea Prothrombin Complex Concentrate Market by Type
10.3.6.5.2 South Korea Prothrombin Complex Concentrate Market by Application
10.3.6.5.3 South Korea Prothrombin Complex Concentrate Market by End Use
10.3.6.6 Rest of Asia-Pacific Prothrombin Complex Concentrate Market
10.3.6.6.1 Rest of Asia-Pacific Prothrombin Complex Concentrate Market by Type
10.3.6.6.2 Rest of Asia-Pacific Prothrombin Complex Concentrate Market by Application
10.3.6.6.3 Rest of Asia-Pacific Prothrombin Complex Concentrate Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Prothrombin Complex Concentrate Market Overview
10.4.2 Middle East and Africa Prothrombin Complex Concentrate Market Forecasts and Analysis
10.4.3 Middle East and Africa Prothrombin Complex Concentrate Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Prothrombin Complex Concentrate Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Prothrombin Complex Concentrate Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Prothrombin Complex Concentrate Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Prothrombin Complex Concentrate Market
10.4.6.1.1 South Africa Prothrombin Complex Concentrate Market by Type
10.4.6.1.2 South Africa Prothrombin Complex Concentrate Market by Application
10.4.6.1.3 South Africa Prothrombin Complex Concentrate Market by End Use
10.4.6.2 Saudi Arabia Prothrombin Complex Concentrate Market
10.4.6.2.1 Saudi Arabia Prothrombin Complex Concentrate Market by Type
10.4.6.2.2 Saudi Arabia Prothrombin Complex Concentrate Market by Application
10.4.6.2.3 Saudi Arabia Prothrombin Complex Concentrate Market by End Use
10.4.6.3 U.A.E Prothrombin Complex Concentrate Market
10.4.6.3.1 U.A.E Prothrombin Complex Concentrate Market by Type
10.4.6.3.2 U.A.E Prothrombin Complex Concentrate Market by Application
10.4.6.3.3 U.A.E Prothrombin Complex Concentrate Market by End Use
10.4.6.4 Rest of Middle East and Africa Prothrombin Complex Concentrate Market
10.4.6.4.1 Rest of Middle East and Africa Prothrombin Complex Concentrate Market by Type
10.4.6.4.2 Rest of Middle East and Africa Prothrombin Complex Concentrate Market by Application
10.4.6.4.3 Rest of Middle East and Africa Prothrombin Complex Concentrate Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Prothrombin Complex Concentrate Market Overview
10.5.2 South and Central America Prothrombin Complex Concentrate Market Forecasts and Analysis
10.5.3 South and Central America Prothrombin Complex Concentrate Market Forecasts and Analysis - By Type
10.5.4 South and Central America Prothrombin Complex Concentrate Market Forecasts and Analysis - By Application
10.5.5 South and Central America Prothrombin Complex Concentrate Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Prothrombin Complex Concentrate Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Prothrombin Complex Concentrate Market
10.5.6.1.1 Brazil Prothrombin Complex Concentrate Market by Type
10.5.6.1.2 Brazil Prothrombin Complex Concentrate Market by Application
10.5.6.1.3 Brazil Prothrombin Complex Concentrate Market by End Use
10.5.6.2 Argentina Prothrombin Complex Concentrate Market
10.5.6.2.1 Argentina Prothrombin Complex Concentrate Market by Type
10.5.6.2.2 Argentina Prothrombin Complex Concentrate Market by Application
10.5.6.2.3 Argentina Prothrombin Complex Concentrate Market by End Use
10.5.6.3 Rest of South and Central America Prothrombin Complex Concentrate Market
10.5.6.3.1 Rest of South and Central America Prothrombin Complex Concentrate Market by Type
10.5.6.3.2 Rest of South and Central America Prothrombin Complex Concentrate Market by Application
10.5.6.3.3 Rest of South and Central America Prothrombin Complex Concentrate Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTHROMBIN COMPLEX CONCENTRATE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PROTHROMBIN COMPLEX CONCENTRATE MARKET, KEY COMPANY PROFILES
13.1. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SANQUIN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CSL BEHRING
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. KEDRION S.P.A
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. OCTOPHARMA AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GRIFOLS, S.A.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Takeda Pharmaceutical Company Limited
2. China Biologic Products Holdings, Inc.
3. Sanquin
4. CSL Behring
5. Kedrion S.p.A
6. Octopharma AG
7. Grifols, S.A.
TIPRE00018528
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking